122 related articles for article (PubMed ID: 12642581)
1. Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4.
Yu S; Asa SL; Weigel RJ; Ezzat S
J Biol Chem; 2003 May; 278(22):19597-602. PubMed ID: 12642581
[TBL] [Abstract][Full Text] [Related]
2. Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage.
Yu SJ; Zheng L; Ladanyi M; Asa SL; Ezzat S
Clin Cancer Res; 2004 Oct; 10(19):6750-8. PubMed ID: 15475466
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary.
Yu S; Asa SL; Ezzat S
Mol Endocrinol; 2002 May; 16(5):1069-78. PubMed ID: 11981041
[TBL] [Abstract][Full Text] [Related]
4. Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter.
Ezzat S; Yu S; Asa SL
Am J Pathol; 2003 Sep; 163(3):1177-84. PubMed ID: 12937159
[TBL] [Abstract][Full Text] [Related]
5. Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasia.
Ezzat S; Zheng L; Asa SL
Mol Endocrinol; 2004 Oct; 18(10):2543-52. PubMed ID: 15231874
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
[TBL] [Abstract][Full Text] [Related]
7. FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1alpha.
Shah RN; Ibbitt JC; Alitalo K; Hurst HC
Oncogene; 2002 Nov; 21(54):8251-61. PubMed ID: 12447688
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the human p11 promoter sequence.
Huang X; Pawliczak R; Yao XL; Madara P; Alsaaty S; Shelhamer JH; Cowan MJ
Gene; 2003 May; 310():133-42. PubMed ID: 12801640
[TBL] [Abstract][Full Text] [Related]
9. A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity.
Wang X; Talamantez JL; Adamo ML
Endocrinology; 1998 Mar; 139(3):1054-66. PubMed ID: 9492038
[TBL] [Abstract][Full Text] [Related]
10. Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cells.
Yu S; Zheng L; Trinh DK; Asa SL; Ezzat S
Lab Invest; 2004 Dec; 84(12):1571-80. PubMed ID: 15467729
[TBL] [Abstract][Full Text] [Related]
11. Involvement of intronic sequences in cell-specific expression of the peripherin gene.
Lecomte MJ; Basseville M; Fauquet M
J Neurochem; 1999 Nov; 73(5):1806-15. PubMed ID: 10537038
[TBL] [Abstract][Full Text] [Related]
12. Transcription of cholesterol side-chain cleavage cytochrome P450 in the placenta: activating protein-2 assumes the role of steroidogenic factor-1 by binding to an overlapping promoter element.
Ben-Zimra M; Koler M; Orly J
Mol Endocrinol; 2002 Aug; 16(8):1864-80. PubMed ID: 12145340
[TBL] [Abstract][Full Text] [Related]
13. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
Cheng YH; Handwerger S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor.
Imhof A; Schuierer M; Werner O; Moser M; Roth C; Bauer R; Buettner R
Mol Cell Biol; 1999 Jan; 19(1):194-204. PubMed ID: 9858544
[TBL] [Abstract][Full Text] [Related]
15. Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites.
Gottschalk LR; Giannola DM; Emerson SG
J Exp Med; 1993 Nov; 178(5):1681-92. PubMed ID: 8228815
[TBL] [Abstract][Full Text] [Related]
16. Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications.
Ezzat S; Zheng L; Winer D; Asa SL
Mol Endocrinol; 2006 Nov; 20(11):2965-75. PubMed ID: 16857743
[TBL] [Abstract][Full Text] [Related]
17. Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter.
Schweppe RE; Gutierrez-Hartmann A
Nucleic Acids Res; 2001 Mar; 29(5):1251-60. PubMed ID: 11222776
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter.
Yu S; Zheng L; Asa SL; Ezzat S
Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E490-5. PubMed ID: 12169442
[TBL] [Abstract][Full Text] [Related]
19. ZNF143 mediates basal and tissue-specific expression of human transaldolase.
Grossman CE; Qian Y; Banki K; Perl A
J Biol Chem; 2004 Mar; 279(13):12190-205. PubMed ID: 14702349
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2).
Xu Y; Porntadavity S; St Clair DK
Biochem J; 2002 Mar; 362(Pt 2):401-12. PubMed ID: 11853549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
